The PE Ratio as of December 2024 (TTM) for Daiichi Sankyo Company, Limited (DSKYF) is 35.30

According to Daiichi Sankyo Company, Limited’s latest financial reports and current stock price. The company's current PE Ratio is 35.30. This represents a change of -9.09% compared to the average of 38.83 of the last 4 quarters.

Daiichi Sankyo Company, Limited (DSKYF) Historical PE Ratio (quarterly & annually)

How has DSKYF PE Ratio performed in the past?

The mean historical PE Ratio of Daiichi Sankyo Company, Limited over the last ten years is 45.91. The current 35.30 PE Ratio has changed 7.59% with respect to the historical average. Over the past ten years (40 quarters), DSKYF's PE Ratio was at its highest in in the March 2021 quarter at 10.21K. The PE Ratio was at its lowest in in the March 2020 quarter at -231.27.

Daiichi Sankyo Company, Limited (DSKYF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Daiichi Sankyo Company, Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Daiichi Sankyo Company, Limited (DSKYF) Average PE Ratio

How has DSKYF PE Ratio performed in the past?

The current PE Ratio of Daiichi Sankyo Company, Limited (DSKYF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Daiichi Sankyo Company, Limited (DSKYF) PE Ratio vs. Peers

How is DSKYF’s PE Ratio compared to its peers?

Daiichi Sankyo Company, Limited’s PE Ratio is less than Astellas Pharma Inc. (50.92), greater than Bristol-Myers Squibb Company PFD CONV 2 (-18.14), less than AstraZeneca PLC (0), greater than Sanofi (31.27), greater than Roche Holding AG (25.51), greater than AstraZeneca PLC (18.89), greater than Bristol-Myers Squibb Company (31.27), greater than Organon & Co. (-16.21), greater than Horizon Therapeutics Public Limited Company (2.96), less than GSK plc (51.10), greater than Novartis AG (21.76), greater than Bayer Aktiengesellschaft (11.14), greater than Amgen Inc. (-21.09), greater than Biogen Inc. (33.41), greater than null (13.52),

Build a custom stock screener for Daiichi Sankyo Company, Limited (DSKYF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Daiichi Sankyo Company, Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Daiichi Sankyo Company, Limited (DSKYF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Daiichi Sankyo Company, Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.